This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Willenbrock, R. Articles by Dietz, R. Search for Related Content PubMed PubMed Citation Articles by Willenbrock, R. Articles by Dietz, R. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB (L)-ALANINE Medline Plus Health Information Heart Failure

(Hypertension. 1996;27:1259-1266.)
© 1996 American Heart Association, Inc.

Articles

Acute and Chronic Neutral Endopeptidase Inhibition in Rats With Aortocaval Shunt

Roland Willenbrock; Michaela Scheuermann; Klaus Höhnel; Friedrich C. Luft; Rainer Dietz

From the Franz Volhard Klinik, Virchow Klinikum, and the Max Delbrück Center for Molecular Medicine, Humboldt University of Berlin (Germany).

Correspondence to Dr Roland Willenbrock, Laboratory for Experimental Heart Failure LEH, Franz-Volhard-Klinik/Max-Delbrück-Centrum, Wiltbergstr. 50, 13125 Berlin, FRG.

Abstract In heart failure, sodium and water retention develop despite elevated plasma levels of atrial natriuretic peptide. Atrial natriuretic peptide is degraded in part by a neutral endopeptidase. Whether neutral endopeptidase inhibition improves sodium and water excretion in heart failure is unknown. We determined the effect of neutral endopeptidase inhibition on plasma levels of atrial natriuretic peptide and the renal response to acute volume expansion in rats with aortocaval shunts and in sham-operated controls. Acute endopeptidase inhibition with SQ 28,603 (30 mg/kg) elevated atrial natriuretic peptide plasma levels in both shunted rats (523±54 to 1258±330 pmol/L, P<.05) and controls (184±28 to 514±107 pmol/L, P<.05). Urinary cGMP excretion, which reflects renal action, increased in parallel. However, the diuretic and natriuretic responses to acute volume expansion were enhanced only in control rats and not in shunted rats. In contrast to the acute effects, chronic neutral endopeptidase inhibition with SCH 34826 (30 mg/kg twice daily) in shunted rats did not change atrial natriuretic peptide plasma levels or cGMP excretion. Nevertheless, the diuretic and natriuretic responses to acute volume load were increased by chronic endopeptidase inhibition in shunted rats (1789±154 to 2674±577 µL/80 min and 99±31 to 352±96 µmol/80 min, respectively; P<.05). Chronic endopeptidase inhibition attenuated the cardiac hypertrophic response to aortocaval shunt without changing arterial blood pressure. Our data show that the renal effects of neutral endopeptidase inhibition are not necessarily dependent on changes in atrial natriuretic peptide plasma levels but instead may be mediated by local inhibition of the neutral endopeptidase in the kidney. In addition, chronic endopeptidase inhibition may attenuate heart failure–induced cardiac hypertrophy independent of hemodynamic effects.

Key Words: heart failure, congestive • atrial natriuretic peptide • endopeptidase, neutral • heart hypertrophy • natriuresis • diuresis

This article has been cited by other articles:

				P. Solter, D. Sisson, W. Thomas, and L. Goetze Intrarenal Effects of Ecadotril during Acute Volume Expansion in Dogs with Congestive Heart Failure J. Pharmacol. Exp. Ther., June 1, 2000; 293(3): 989 - 995. [Abstract] [Full Text]

				R. Willenbrock, M. Scheuermann, G. Thibault, Markus Haass, K. Hohnel, J. Bohlender, F. C. Luft, and Rainer Dietz Angiotensin inhibition and atrial natriuretic peptide release after acute volume expansion in rats with aortocaval shunt Cardiovasc Res, June 1, 1999; 42(3): 733 - 742. [Abstract] [Full Text] [PDF]

				R. WILLENBROCK, I. PAGEL, M. SCHEUERMANN, K. HÖHNEL, H. S. MACKENZIE, B. M. BRENNER, and R. DIETZ Renal Function in High-Output Heart Failure in Rats: Role ofEndogenous Natriuretic Peptides J. Am. Soc. Nephrol., March 1, 1999; 10(3): 572 - 580. [Abstract] [Full Text]

				D. J. Campbell, F. Anastasopoulos, A.-M. Duncan, G. M. James, A. Kladis, and T. A. Briscoe Effects of Neutral Endopeptidase Inhibition and Combined Angiotensin Converting Enzyme and Neutral Endopeptidase Inhibition on Angiotensin and Bradykinin Peptides in Rats J. Pharmacol. Exp. Ther., November 1, 1998; 287(2): 567 - 577. [Abstract] [Full Text]

				S. A Doggrell and L. Brown Rat models of hypertension, cardiac hypertrophy and failure Cardiovasc Res, July 1, 1998; 39(1): 89 - 105. [Full Text] [PDF]

				F. Anastasopoulos, R. Leung, A. Kladis, G. M. James, T. A. Briscoe, T. P. Gorski, and D. J. Campbell Marked Difference between Angiotensin-Converting Enzyme and Neutral Endopeptidase Inhibition in Vivo by a Dual Inhibitor of Both Enzymes J. Pharmacol. Exp. Ther., March 1, 1998; 284(3): 799 - 805. [Abstract] [Full Text]

				R. Willenbrock, H. Stauss, M. Scheuermann, K. J. Osterziel, T. Unger, and R. Dietz Effect of chronic volume overload on baroreflex control of heart rate and sympathetic nerve activity Am J Physiol Heart Circ Physiol, December 1, 1997; 273(6): H2580 - H2585. [Abstract] [Full Text] [PDF]